Literature DB >> 32531467

Fournier's Gangrene in Females: Presentation and Management at a Tertiary Center.

Nicholas J Beecroft1, Christopher D Jaeger1, Justin R Rose1, Clara M Castillejo Becerra1, Nayan C Shah1, Marilly S Palettas1, Amy Lehman1, Tasha Posid1, Lawrence C Jenkins1, Nima Baradaran2.   

Abstract

OBJECTIVE: To report and compare presentation and management of Fournier's Gangrene (FG) in female vs male patients at a single tertiary care center.
METHODS: Patient demographics, clinical characteristics, treatments and outcomes were summarized and compared between males and females who were treated for FG from 2011 to 2018 at a single institution.
RESULTS: Of the 143 patients treated for FG at our institution, 33 (23%) were female. Female patients were predominantly white (82%), with a median (IQR) age of 55 (46, 59). Median female boby mass index (BMI) was 42.1 (32, 50.4). Female patients' wound cultures were polymicrobial mix of gram positive and gram negative organisms. Median number of debridements for females was 2 (1,3). The most common anatomic region of gangrene involvement in females was labia (76%) followed by perineum (55%) and gluteus/buttocks (42%). Mortality rate during initial admission was 6% for females. Female patients had a higher median BMI than males (42.1 vs 33.7 respectively; P = .003). FG severity index, length of hospital stay, number of debridements, and wound cultures were comparable to males. The surgical team managing initial debridements differed with females managed primarily by general surgery and males primarily by urology. Mortality rate was comparable to men (6% vs 7%, P >.05).
CONCLUSION: Female patients with FG have greater BMI but similar clinical presentation, microbiologic characteristics and mortality rate compared to men. Urologists have little involvement during initial management for females at our institution.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32531467     DOI: 10.1016/j.urology.2020.05.056

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

Review 1.  Fournier's Gangrene under Sodium-Glucose Cotransporter-2 Inhibitors Therapy in Gynecological Patients.

Authors:  Adriana Serrano Olave; Ana Isabel Bueno Moral; Carmen Martínez Bañón; Ernesto González Mesa; Jesús S Jiménez López
Journal:  Int J Environ Res Public Health       Date:  2022-05-21       Impact factor: 4.614

Review 2.  Practical Review of the Current Management of Fournier's Gangrene.

Authors:  Maria T Huayllani; Amandip S Cheema; Matthew J McGuire; Jeffrey E Janis
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-03-14

3.  Management of Fournier's gangrene during the Covid-19 pandemic era: make a virtue out of necessity.

Authors:  Alessio Paladini; Giovanni Cochetti; Angelica Tancredi; Matteo Mearini; Andrea Vitale; Francesca Pastore; Paolo Mangione; Ettore Mearini
Journal:  Basic Clin Androl       Date:  2022-07-19

4.  Fournier's gangrene in female patient with Turner's syndrome: A case report.

Authors:  Jupiter Sibarani; Alwin Soetandar
Journal:  Urol Case Rep       Date:  2022-06-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.